We are live on ! Find out more
DMII

Drugs Made In America Acquisition II Corp
DMII

51 hedge funds and large institutions have $343M invested in Drugs Made In America Acquisition II Corp in 2025 Q4 according to their latest regulatory filings, with 51 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

54.51% more ownership

Funds ownership: 0% → 54.51% (+55%)

Holders
51
Holders Change
+51
Holders Change %
–
% of All Funds
0.62%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
51
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MF
Magnetar Financial
Illinois
+$26.7M
2
GCL
Glazer Capital LLC
New York
+$23.2M
3
FTCM
First Trust Capital Management
Illinois
+$20.4M
4
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$19.5M
5
Millennium Management
Millennium Management
New York
+$14.8M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SC
26
Sculptor Capital
New York
$4.95M +$4.94M +500,000 New
WA
27
Whitebox Advisors
Minnesota
$4.46M +$4.45M +450,000 New
SCM
28
Shaolin Capital Management
Florida
$4.21M +$4.2M +425,000 New
WC
29
Wealthspring Capital
New York
$4.05M +$4.04M +408,950 New
COPPSERS
30
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$3.96M +$3.95M +400,000 New
BNP Paribas Financial Markets
31
BNP Paribas Financial Markets
France
$3.45M +$3.45M +348,600 New
LPC
32
Lineage Point Capital
Florida
$3.33M +$3.33M +336,360 New
SAMU
33
SONA Asset Management (US)
New York
$2.97M +$2.97M +300,000 New
PC
34
Periscope Capital
Ontario, Canada
$2.63M +$2.62M +265,500 New
MTCM
35
Mint Tower Capital Management
Netherlands
$2.48M +$2.47M +250,000 New
Verition Fund Management
36
Verition Fund Management
Connecticut
$1.98M +$1.98M +200,000 New
Toronto Dominion Bank
37
Toronto Dominion Bank
Ontario, Canada
$1.88M +$1.88M +189,909 New
CS
38
Clear Street
New York
$1.8M +$1.79M +181,521 New
JP Morgan Chase
39
JP Morgan Chase
New York
$1.28M +$1.28M +129,630 New
MSU
40
Mizuho Securities USA
New York
$1.26M +$2.14M +216,307 New
DAM
41
DLD Asset Management
New York
$1.11M +$1.11M +112,200 New
CCC
42
Cable Car Capital
California
$990K +$989K +100,000 New
PEAK6
43
PEAK6
Illinois
$990K +$989K +100,000 New
QL
44
Quarry LP
New York
$990K +$989K +100,000 New
Royal Bank of Canada
45
Royal Bank of Canada
Ontario, Canada
$655K +$654K +66,200 New
DAM
46
Deltec Asset Management
New York
$495K +$494K +50,000 New
AA
47
ABC Arbitrage
France
$396K +$395K +40,000 New
DWM
48
Dakota Wealth Management
Florida
$365K +$364K +36,825 New
VF
49
Virtu Financial
New York
$317K +$316K +31,991 New
Geode Capital Management
50
Geode Capital Management
Massachusetts
$265K +$265K +26,801 New
1
2
3

DMII Hedge Fund Activity: Q4 2025 in Review

51 of the 8,256 institutional investors tracked by Wall St. Rank reported a position in Drugs Made In America Acquisition II Corp (DMII) for Q4 2025, worth a combined $343M.

Buyers outnumbered sellers: 51 funds opened new DMII positions and 0 closed out — a net gain of 51 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Magnetar Financial, opening a new position worth an estimated $26.7M.

  • 51 institutional investors held Drugs Made In America Acquisition II Corp (DMII) as of Q4 2025, up from 0 in Q3 2025.
  • Funds reported $343M of Drugs Made In America Acquisition II Corp stock for Q4 2025.
  • 51 funds opened new Drugs Made In America Acquisition II Corp positions in Q4 2025 and 0 closed out, a net change of +51 holders.
  • The largest Drugs Made In America Acquisition II Corp buyer in Q4 2025 was Magnetar Financial, an estimated $26.7M added.

Based on aggregated 13F filings for Q4 2025.